Moore Capital Management LP trimmed its position in Ralliant Corporation (NYSE:RAL – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 241,098 shares of the company’s stock after selling 11,592 shares during the period. Moore Capital Management LP’s holdings in Ralliant were worth $12,274,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Phocas Financial Corp. boosted its holdings in Ralliant by 81.2% in the 4th quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock worth $7,999,000 after buying an additional 70,403 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Ralliant by 10.7% in the 3rd quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock worth $637,995,000 after buying an additional 1,415,327 shares during the last quarter. SG Capital Management LLC acquired a new stake in Ralliant in the 3rd quarter worth about $8,139,000. Victory Capital Management Inc. boosted its holdings in Ralliant by 1,726.7% in the 3rd quarter. Victory Capital Management Inc. now owns 873,794 shares of the company’s stock worth $38,211,000 after buying an additional 825,960 shares during the last quarter. Finally, Clean Energy Transition LLP boosted its holdings in Ralliant by 70.1% in the 3rd quarter. Clean Energy Transition LLP now owns 900,903 shares of the company’s stock worth $39,396,000 after buying an additional 371,419 shares during the last quarter.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on RAL. Royal Bank Of Canada boosted their target price on Ralliant from $47.00 to $64.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 13th. Morgan Stanley boosted their target price on Ralliant from $45.00 to $68.00 and gave the stock an “overweight” rating in a report on Thursday, May 14th. Evercore began coverage on Ralliant in a report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 target price on the stock. Truist Financial restated a “buy” rating and set a $68.00 target price (up from $53.00) on shares of Ralliant in a report on Wednesday, May 13th. Finally, TD Cowen boosted their target price on Ralliant from $55.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, May 20th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $67.30.
Ralliant Trading Down 1.8%
RAL opened at $67.50 on Thursday. Ralliant Corporation has a one year low of $37.27 and a one year high of $70.22. The stock has a market capitalization of $7.56 billion and a PE ratio of -6.17. The business’s 50 day moving average price is $54.62 and its 200 day moving average price is $50.26. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61.
Ralliant (NYSE:RAL – Get Free Report) last announced its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.08. The company had revenue of $534.60 million for the quarter. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.Ralliant’s revenue for the quarter was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. As a group, equities research analysts expect that Ralliant Corporation will post 2.64 EPS for the current year.
Ralliant Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be issued a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Monday, June 8th. Ralliant’s dividend payout ratio is -1.83%.
Ralliant Company Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Featured Stories
- Five stocks we like better than Ralliant
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL – Free Report).
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
